Cardiol Therapeutics Announces Year-End 2022 Update on Opera

Cardiol Therapeutics Inc. , a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart... | March 29, 2023

Related Keywords

United States , Israel , Dallas , Texas , United Kingdom , Boston , Massachusetts , Oakville , America , British , American , Josepha Hill , David Elsley , Jenniferm Chao , Teri Loxam , Paulm Ridker , Chris Waddick , Bruce Mcmanus , American Heart Association , American Heart Association Scientific Sessions , Kira Pharmaceuticals , Company Annual , Newsfile Corp , Laboratory Medicine , Department Of Pathology , Harrys Moss Heart Center , Compensation Committee , Cardiol Therapeutics Inc , University Of British Columbia , Chao Is Managing Partner Of Corestrategies Management , Scientific Program , Virginia Commonwealth University , Ut Southwestern Medical Center , Company Phase , Houston Methodist Debakey Heart Vascular Center , Drug Administration , Nasdaq , Annual Scientific Meeting , Heart Failure Society , Scientific Advisory , Financial Statements , Cleveland Clinic , Mayo Clinic , Chief Executive Officer , Investigational New Drug Application , North America , Latin America , Houston Methodist Debakey Heart , Vascular Center , Inhibits Endothelial To Mesenchymal Transition , Reverse Process , Pharmaceutically Manufactured Cannabidiol , Mouse Model , Breaking Basic Science , Cardiovascular Disease Prevention , Eugene Braunwald Professor , Harvard School , Professor Emeritus , Internal Medicine , Molecular Biology , Medical Center , Corporate Governance , Managing Partner , Corestrategies Management , Chief Operating Officer , Chief Financial Officer , Corporate Secretary , Company Sponsored Phase , United States Food , Cardiol Therapeutics , Annual Report , Cardiol Therapeutics Inc Stock Exchange , News , Information , Press Release , Cardiol , Herapeutics , Life , Ciences , Company , Ocused , N , The , Research , End , Linical , Development , F , Therapies , Or , Treatment , F Crdl Ca14161y2006 ,